Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Seneca Global Income & Grwth

29 Nov 2016 12:02

RNS Number : 4461Q
Seneca Global Income & Growth PLC
29 November 2016
 

 

London, UK, 29 November 2016

Edison issues research review on Seneca Global Income & Growth Trust (SIGT)

 

Seneca Global Income & Growth Trust (SIGT) aims to generate income and long-term capital growth from a range of asset classes. Investments are made for the long term using a strategic asset allocation to equities (60%: 35% UK and 25% overseas, with modest US exposure), fixed income (15%) and specialist assets (25%, including property and infrastructure assets, where yields can be in the 5-8% range). Around one-third of the fund is invested in UK mid-caps, where over time returns tend to be higher than for large-caps, and where the market is generally less efficient, providing opportunities for stock picking. There is no exposure to safe-haven government bonds, which the managers consider unattractively valued, and SIGT has lower FX exposure than its peers. Following a change in investment mandate in 2012, SIGT's NAV total return has meaningfully outperformed the FTSE All-Share index, with significantly lower volatility.

 

SIGT's current 1.8% share price premium to cum-income NAV compares to the average 0.6% premium of the last 12 months and the average discounts of the last three, five and 10 years (3.2%, 6.4% and 7.2%, respectively). While SIGT has no formal income target, the board states that it wants to pursue a progressive dividend policy. The annual dividend has been increased each year since 2013; the prospective dividend yield is 3.8%.

Click here to view the full report

 

All reports published by Edison are available to download free of charge from its website: www.edisoninvestmentresearch.com

 

About Edison: Edison is an international equity research firm with a team of over 70 analysts, investment and roadshow professionals and works with both large and smaller capitalised companies, blue chip institutional investors, wealth managers, private equity and corporate finance houses to support their capital markets activity. Edison provides services to more than 420 retained corporate and investor clients from offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority.

 

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

Contact details: Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn

www.linkedin.com/company/edison-investment-research

Twitter

www.twitter.com/Edison_Inv_Res

YouTube

www.youtube.com/edisonitv

Google+

https://plus.google.com/105425025202328783163/posts

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKLFLQFFEFBV
Date   Source Headline
1st Apr 20215:13 pmRNSTransaction in Own Shares
1st Apr 20212:31 pmRNSChange of Name
1st Apr 20211:41 pmRNSNet Asset Value(s)
1st Apr 20219:32 amRNSTotal Voting Rights
31st Mar 20211:09 pmRNSNet Asset Value(s)
30th Mar 202112:27 pmRNSNet Asset Value(s)
29th Mar 20215:22 pmRNSTransaction in Own Shares
29th Mar 202112:57 pmRNSNet Asset Value(s)
26th Mar 202110:28 amRNSNet Asset Value(s)
25th Mar 202112:52 pmRNSDirector/PDMR Shareholding
25th Mar 202110:25 amRNSNet Asset Value(s)
24th Mar 20215:19 pmRNSTransaction in Own Shares
24th Mar 202111:14 amRNSNet Asset Value(s)
23rd Mar 202111:46 amRNSNet Asset Value(s)
22nd Mar 202110:58 amRNSNet Asset Value(s)
19th Mar 202111:42 amRNSHolding(s) in Company
19th Mar 202111:38 amRNSNet Asset Value(s)
18th Mar 202111:28 amRNSNet Asset Value(s)
17th Mar 202111:58 amRNSNet Asset Value(s)
16th Mar 202111:26 amRNSNet Asset Value(s)
15th Mar 20214:46 pmRNSTransaction in Own Shares
15th Mar 202110:00 amRNSNet Asset Value(s)
12th Mar 202110:57 amRNSNet Asset Value(s)
11th Mar 202110:34 amRNSNet Asset Value(s)
10th Mar 202110:51 amRNSNet Asset Value(s)
9th Mar 20215:06 pmRNSTransaction in Own Shares
9th Mar 202111:33 amRNSNet Asset Value(s)
8th Mar 202111:38 amRNSNet Asset Value(s)
5th Mar 20214:38 pmRNSTransaction in Own Shares
5th Mar 202110:39 amRNSNet Asset Value(s)
4th Mar 202112:18 pmRNSNet Asset Value(s)
3rd Mar 20214:58 pmRNSTransaction in Own Shares
3rd Mar 202111:17 amRNSNet Asset Value(s)
2nd Mar 20212:40 pmRNSTransaction in Own Shares
2nd Mar 202110:39 amRNSNet Asset Value(s)
1st Mar 20214:37 pmRNSTransaction in Own Shares
1st Mar 202111:43 amRNSNet Asset Value(s)
1st Mar 202110:14 amRNSTotal Voting Rights
26th Feb 20214:54 pmRNSTransaction in Own Shares
26th Feb 202112:00 pmRNSNet Asset Value(s)
25th Feb 202111:29 amRNSNet Asset Value(s)
24th Feb 20214:44 pmRNSTransaction in Own Shares
24th Feb 202110:14 amRNSNet Asset Value(s)
23rd Feb 202112:09 pmRNSNet Asset Value(s)
22nd Feb 202111:23 amRNSNet Asset Value(s)
19th Feb 20215:05 pmRNSTransaction in Own Shares
19th Feb 20211:07 pmRNSNet Asset Value(s)
18th Feb 20214:54 pmRNSTransaction in Own Shares
18th Feb 202110:00 amRNSNet Asset Value(s)
17th Feb 202110:48 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.